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Abstract
In nearly 1 month, with a rapidly expanding corona virus
disease 2019 (COVID-19), telemedicine has been transformed into an essential service for delivering routine clinical
care. This transformation occurred as a crisis management
response—driven by the need to provide care for patients
with physical distancing measures in place. However, the
current rapid adoption of telemedicine presents a transitional state between one that existed before the pandemic
and one that could potentially be better aligned with the
delivery of a personalized model of care. Using the conceptual framework of digital translucence—situating virtual
encounters with more nuanced information regarding
patients—we describe the role of integrated remote monitoring
and virtual care tools aligned with the patient’s electronic health record for adapting telemedicine delivery postCOVID-19.
Keywords: telemedicine, electronic health records, pandemic,
artificial intelligence, m-health

T

elemedicine has the potential to expand the reach
and capabilities of clinical care ranging from delivering care in rural settings to remote monitoring
of patients during and after hospitalizations.1 Even
with technological advances, a 2018 Centers for Medicare
and Medicaid Services (CMS) report found that telemedicine encounters involved only 3% of its fee-for-service
beneficiaries.2 However, in nearly 1 month, with a rapidly
expanding corona virus disease 2019 (COVID-19) pandemic,
additional federal funding, and the loosening of regulatory
provisions, telemedicine has transformed into an essential

service for delivering care.3 The New York Times aptly called
this abrupt transformation as ‘‘10 years of change in one
week.’’4
This transformation occurred as a crisis management
response—driven by the need to provide care for patients with
physical distancing measures in place.5 However, current infrastructure for telemedicine can be described as necessary,
although rudimentary. The rapid adoption of telemedicine
presents a transitional state: one that currently exists and
one that could be better aligned with the personalized,
predictive, preventive, participatory, psychocognitive, and
public model of medicine.6 There exists a real opportunity
to operationalize ‘‘health web science’’—a combination of
telemedicine and e-health—on a national scale, wherein
patient-generated health data can be actively used in targeted preventive care, wellness, and treatment. This is especially important as recent reports have highlighted the
lasting toll of COVID-19 on mental health and well-being,
and have suggested telemedicine as a strategic solution to
the secondary pandemic that may quickly follow—that of
mental and behavioral illnesses (e.g., anxiety and depression)7 and chronic comorbidities (e.g., cardiovascular
diseases).
For telemedicine to be a viable solution after this pandemic,
as health systems face increased demands for mental and
chronic care services, current telemedicine processes must
be adapted. This is because telemedicine visits are touchless,
introducing a level of opaqueness to the patient–provider
interaction that is potentially not conducive to routine patient
care and support. During telemedicine encounters, digital
environments mediate provider–patient interactions, affecting the quality of interactive communication. In design terms,
translucence—or the ability to provide visibility, context, and
awareness during interactions—can help in overcoming
opacity.8
Metaphorically, translucence can be visualized using a
two-way door: one wooden and opaque with a sign that
says ‘‘open slowly’’ versus a glass door that serves the same
purpose, but engenders different user interactions. It is
hard to predict how users would interact with a wooden
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door, with some people following the posted sign and
others ignoring or not seeing it; in contrast, a glass door
allows seamless interactions, nullifying the need for instructions.9 In a telemedicine context, ‘‘the glass door’’ can
be described as digital translucence, a concept that entails
creating digital features for situating patient–provider interactions.
Here, we describe two possible considerations for adapting
telemedicine to future care delivery post-COVID-19, using a
health web science approach to integrate remote monitoring
and virtual care tools, all aligned with the electronic health
record (EHR).
First, digital translucence in telemedicine can be enhanced
by incorporating remote monitoring using mobile technology. Mobile and wearable devices can be used to track a
number of physiological (e.g., heart rate) and physical activities (e.g., steps). Such patient-generated health data
should be (1) captured using seamless interfaces that are
integrated with the EHR, (2) used to develop digital phenotypes using machine algorithms for generating clinically
meaningful insights (e.g., predicting fall risk for an older
patient), and (3) presented using innovative visualization
techniques for assisting in clinical decision making at the
point-of-care (e.g., physical activity for a chronic heart
failure patient).
Achieving these would require data and algorithms to be
integrated within an EHR workflow, allowing providers access
to clinically informative findings from these data similar
to how they access other clinical data. Such access affords
clinicians a window into a patient’s routines, situating and
contextualizing the telemedicine discussions. For this, patients should be able to easily share their data seamlessly
through their patient portal within an EHR. In cases wherein
such native features do not exist, integration efforts must
utilize EHR interfaces such as fast health interoperability
resources, allowing for platform–agnostic integration.10 Such
data exchange formats will help in incorporating novel predictive algorithms and in creating an ecology of applications
that can be shared and used across multiple health care
systems.
In addition, physical, behavioral, and emotional health
indicators should be captured using Patient-Reported Outcomes Measurement Information System (PROMIS) or similar adaptive techniques. Integrating PROMIS tools within an
EHR allows for longitudinal tracking of patient progress,
and also automated administering, scoring, viewing, and
diagnostic interpretation, providing clarity during telemedicine encounters.

Second, ensuring continuity of care is an important consideration for successful telemedicine encounters. One of
the fast growing areas, spurred by advances in artificial
intelligence, is that of conversational agents.11 Traditional
conversational agents, relying on text-based interactions,
play an important role helping patients with basic self-care
and health maintenance tasks (e.g., medication reminders).12
More recently, with voice-based personal devices gaining
popularity (e.g., Alexa), there is considerable interest in virtual
agents for delivering structured, evidence-based behavioral
counseling, and wellness interventions. Similar to seeking
care from a therapist, these virtual services can provide ongoing support; these should also require ‘‘referrals’’ from
within an EHR, with the ability to track patient adherence, use
and progress, and to coordinate patient care over time. This
would require integration of the virtual applications within
the EHR, and additional research efforts regarding the conceptual, technical, and privacy implications.
As health care systems eventually return to a new normal,
telemedicine is inevitably going to be an integral part. Although it is difficult to predict how ‘‘routine practice’’ will
return, in a rare upside to the pandemic, we have an opportunity to create a positive impact with a strategic vision
for telemedicine to achieve translucence by incorporating
digital tools that can result in more meaningful and situated
practice. With foresight, health systems that leverage the
telemedicine transition to incorporate delivery processes to
integrate patient-generated health data and virtual care
platforms will emerge out of the pandemic to better meet the
increases in mental and chronic health care needs among
their patients.
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